Company Filing History:

56 out of 1,459

Smc Corporation

patents

2 out of 237

Banyu Pharmaceutical Co. Ltd

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 1995-2010

Loading Chart...

59 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7728025 - 2-heteroaryl-substituted benzimidazole derivative (2010-06-01),

2. 7727998 - Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient (2010-06-01),

3. 7700611 - Synthesis and crystalline forms of NPY5 antagonist (2010-04-20),

4. 7591280 - Manifold-type solenoid valve assembly (2009-09-22),

5. 6959910 - Solenoid valve having manually-operated device (2005-11-01),

6. 6913037 - Manifold valve with sensors (2005-07-05),

7. 6874537 - Manifold valve (2005-04-05),

8. 6840273 - Manifold valve having position detecting mechanism (2005-01-11),

9. 6820859 - Body for valve and method for manufacturing the same (2004-11-23),

10. 6807981 - Manifold for electromagnetic valve (2004-10-26),

11. D479738 - Electromagnetic valve (2003-09-17),

12. D479308 - Electromagnetic valve (2003-09-03),

13. 6612333 - Selector valve with magnetometric sensor (2003-09-02),

14. 6612332 - Solenoid valve having sensor (2003-09-02),

15. 6520202 - Manifold valve having position detecting function (2003-02-18),

Title: **Innovations of Makoto Ishikawa: A Pioneer in Pharmaceutical Patents**

Introduction

Makoto Ishikawa, based in Tsukuba-gun, Japan, is a renowned inventor with an impressive portfolio of 59 patents. His work prominently features advancements in pharmaceutical sciences, showcasing his commitment to improving health outcomes through innovative inventions.

Latest Patents

Ishikawa's latest patents highlight significant contributions to medical treatments. One of his notable inventions includes melanin-concentrating hormone receptor antagonists containing piperidine derivatives. This invention provides a novel class of compounds aimed at treating various conditions related to obesity and metabolic disorders.

Another remarkable patent involves a glucokinase activator characterized by a 2-heteroaryl-substituted benzimidazole derivative. This innovation has potential applications as a remedy and preventive measure for diabetes, along with associated complications such as retinopathy, nephropathy, neurosis, ischemic cardiopathy, and arteriosclerosis. The detailed formula of this compound, which includes various structural components, underscores his expertise in medicinal chemistry.

Career Highlights

Throughout his career, Ishikawa has collaborated with prominent organizations such as SMC Corporation and Banyu Pharmaceutical Co. Ltd. These experiences have enriched his knowledge and broadened his impact in the pharmaceutical industry.

Collaborations

Ishikawa has also worked alongside notable colleagues, including Bunya Hayashi and Shinji Miyazoe. Their partnerships have led to innovative approaches and methodologies in drug development, further enhancing the efficacy of their research endeavors.

Conclusion

Makoto Ishikawa's journey as an inventor reflects his dedication to advancing healthcare through innovative solutions. With a robust portfolio of patents and successful collaboration with leading companies and talented colleagues, he continues to make significant strides in the realm of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.